Clinical Conversations

Clinical Conversations

Download on the App Store

All Clinical Conversations episodes

  • Podcast 154: Treating heart failure’s hypercoagulable state — warfarin or aspirin?

    Heart failure brings problems associated with hypercoagulation, such as stroke and sudden death.

    An international study followed some 2300 patients with heart failure (ejection fractions of 35% or less) and in stable sinus rhythm for a mean of 3.5 years, randomizing them to treatment with either warfarin or aspirin.

    The two treatment groups showed about the same risks for stroke and overall mortality, but warfarin was associated with more major bleeding episodes.

    Our guest is the first author on the report, released online by the New England Journal of Medicine.

    Links:

    NEJM article

    The post Podcast 154: Treating heart failure’s hypercoagulable state — warfarin or aspirin? first appeared on Clinical Conversations.
    11 min
  • Podcast 153: Type 2 diabetes in young people — tough going on the treatment front

    About half of adolescents with type 2 diabetes fail treatment with metformin alone within a few years. Things go somewhat better with metformin plus an intensive lifestyle intervention, and better still with the addition of rosiglitazone to metformin — however even the addition of the second drug leads to treatment failure about 40% of the time.

    What’s to be done? On the basis of the evidence collected by the TODAY investigators, the problem has as many metabolic as social dimensions. Clearly, drugs alone are not the answer here.

    Dr. Phil Zeitler, the TODAY study chair talks with Clinical Conversations about his surprise at the higher rate of failure with metformin monotherapy among adolescents than among adults, and what lessons this study holds.

    Links:

    Physician’s First Watch summary (free)

    New England Journal of Medicine article (free)

    New England Journal of Medicine editorial (free)

    The post Podcast 153: Type 2 diabetes in young people — tough going on the treatment front first appeared on Clinical Conversations.
    13 min
  • Podcast 152: Gum disease and atherosclerosis — evidence for an association, but not for a cause-and-effect

    The American Heart Association’s scientific statement on “Periodontal Disease and Atherosclerotic Vascular Disease” is likely to raise hackles among those offering treatments for gum disease as a way to lower risk for heart disease — or even to ameliorate it. The association’s writing committee, after a 4-year review of the evidence, finds no support for such treatments and calls any assertions to the contrary “unwarranted.”

    We interview the Dr. Peter Lockhart, co-chair of the AHA’s committee.

    Links:

    American Heart Association statement (free)

    The post Podcast 152: Gum disease and atherosclerosis — evidence for an association, but not for a cause-and-effect first appeared on Clinical Conversations.
    9 min
  • Podcast 151: Most people above age 10 have at least some cross-reactive antibodies to variant influenza

    Influenza A (H3N2)v — a novel flu virus that emerged last summer and shows signs of being able to transmit itself from person to person — is our topic this week.

    The virus carries genes from swine and avian flu viruses, and the few cases found in the U.S. all made complete recovery.

    We talk with CDC epidemiologists involved in assessing the threat, and they’re reassuring on two fronts: first of all, most of the population shows at least some cross-reactive antibody to the virus; and second, they’ve isolated a candidate vaccine virus that they would use in the event that A (H3N2)v started showing increased ability for person-to-person transmission.

    Links:

    • MMWR article on influenza A (H3N2)v antibodies (free)
    • CDC advice on treating influenza A (H3N2)v (free)
    • Physician’s First Watch coverage (free)
    • The post Podcast 151: Most people above age 10 have at least some cross-reactive antibodies to variant influenza first appeared on Clinical Conversations.
      12 min
    • Podcast 150: Depression (and antidepressant use) after stroke or TIA

      After stroke or transient ischemic attack, depression is more common than among the general population, and the risk for depression extends beyond the early time period after the event.

      More alarmingly, less than a third of those with persistent depression — defined as depression detected both at 3 and 12 months after the cerebrovascular event — receive antidepressant medication.

      We offer an interview with Dr. Nada El Husseini, first author of a study published online in Stroke that presents the data supporting those observations.

      Link:

      Stroke abstract (free)

      Physician’s First Watch summary (free)

      The post Podcast 150: Depression (and antidepressant use) after stroke or TIA first appeared on Clinical Conversations.
      10 min
    • Podcast 149: High levels of white rice consumption seem linked to higher risks for type 2 diabetes

      A BMJ meta-analysis suggests that people with the highest levels of white rice consumption are at increased risk for type 2 diabetes.

      The authors examined four studies, together comprising some 350,000 subjects. Two were done in Asian populations and two among Westerners. They found a much higher intake of white rice among Asians, and a strong association between consumption level and risk. In Western populations, the association was suggestive, but not as strong.

      The effect may possibly derive from the higher glycemic load with increasing consumption, or from the nutrients stripped away with the rice husk during milling.

      The senior author, Dr. Qi Sun, discusses his findings with us in a brief interview.

      Links:

      BMJ article (free)

      The post Podcast 149: High levels of white rice consumption seem linked to higher risks for type 2 diabetes first appeared on Clinical Conversations.
      11 min
    • Podcast 148: Smoking cessation during pregnancy is probably more effective with behavioral approaches than with relying on nicotine replacement

      In the largest study of its kind, UK researchers find that helping pregnant women to quit smoking until at least delivery isn’t helped much by nicotine replacement therapy.

      The primary outcome, self-reported cessation lasting between the start of therapy and delivery, differed little between the active treatment group and those randomized to placebo (9% versus 8%).

      In addition, compliance was low in both groups.

      Links

      New England Journal of Medicine abstract (free)

      The post Podcast 148: Smoking cessation during pregnancy is probably more effective with behavioral approaches than with relying on nicotine replacement first appeared on Clinical Conversations.
      11 min
    • Podcast 147: Proof that colonoscopy with polypectomy saves lives

      Everyone “knows” that colonoscopy reduces risks of death from colorectal cancer, but it’s good to have your knowledge actually verified, and a new bit of research seems to do that in this case.

      Long-term follow-up of a group of patients who underwent colonoscopy and polypectomy in the 1980s shows that removal of adenomatous polyps brought with it a risk of dying from colorectal that was half the risk found in the general population. About 80% of these patients, it should be mentioned, underwent strict surveillance for 10 years after their adenomatous polyps were excised.

      This is good news, no? And it offers clinicians a “teaching moment” with their patients who are reluctant to undergo the procedure.

      Listen in as we interview Dr. Ann Zauber, first author on the New England Journal of Medicine paper.

      Links:

      Physician’s First Watch coverage of the research (free)

      New England Journal of Medicine abstract (free)

      New England Journal of Medicine editorial (subscription required)

      The post Podcast 147: Proof that colonoscopy with polypectomy saves lives first appeared on Clinical Conversations.
      12 min
    • Podcast 146: Cognitive impairment in primary care — screen or not?

      Current guidelines find no compelling therapeutic benefit to screening for cognitive impairment and dementia in primary care. The Journal of the American Geriatrics Society has published some research that, if not compelling, certainly suggests that clinical approaches should change.

      In actively screening some 8000 veterans over age 70 during routine primary care visits for cognitive impairment, researchers found a quarter to have signs suggesting further investigation was needed. When all was said and done, 11% had cognitive impairment; that’s two to three times the rate found in settings where physicians waited for impairment to manifest itself clinically.

      We interview the lead author, who offers reasons why he thinks simple screening should be routine in elderly populations, despite the current absence of treatments for mild cognitive impairment and dementia.

      Links:

      Physician’s First Watch coverage (free)

      Journal of the American Geriatrics Society abstract (free)

      USPSTF current screening guidelines (free)

      Mini-Cog screening test (free)

      The post Podcast 146: Cognitive impairment in primary care — screen or not? first appeared on Clinical Conversations.
      13 min
    • Podcast 145: The Y chromosome and the possible role of a common variant in coronary disease in men.

      Haplogroups — who knew? Ancient variations in the Y chromosome form what’s known as haplogroups, and haplogroup I is common in Europe, particularly so in northern Europe. Researchers find that “I” is an independent risk factor for coronary artery disease in men, carried as it is on the male-only Y chromosome.

      Listen in as we talk ancient genetics and what it all could mean for a range of immune-system-related diseases. There’s plenty of work to be done, but we thought you ought to know about this earlier rather than later.

      Links:

      • Physician’s First Watch coverage (free)
      • Lancet abstract (free)
      • The post Podcast 145: The Y chromosome and the possible role of a common variant in coronary disease in men. first appeared on Clinical Conversations.
        14 min